CommercialCoverageLow impact
Tier change for Naloxone products
Blue Cross Blue Shield of Rhode Island·RI · Psychiatry, Pain Management, Family Medicine +2 more·Behavioral Health
Effective date
Feb 1, 2020
We identified it
Jun 19, 2026
Summary
BCBSRI moved all Naloxone products (including brand Narcan nasal spray and generic naloxone injectable) to tier one pharmacy copay to improve access during the opioid epidemic. This reduces patient out-of-pocket costs to the lowest copayment tier for life-saving overdose reversal medications.
Action Required
No immediate action required for billing team. This is a pharmacy benefit change that reduces patient copays for Naloxone products. If patients ask about Naloxone costs, inform them it's now available at tier one copay rates through BCBSRI pharmacy benefits.